In: Pharmaceuticals

The Drug Development Process: A Rube Goldberg of Life Sciences?

A Rube Goldberg contraption is an over-engineered machine that uses chain reactions to accomplish the simplest of tasks in the most…

Read More
Massachusetts Paves the Way for Rare Disease and Orphan Drug Development

A recent article in the Boston Business Journal has revealed the full extent of the Bay State’s booming rare disease research…

Read More
Animal Biotechnology Part Two: Advances in the Veterinary Space

As we learned in part one of this series, the field of animal biotechnology consists of two main arms of research….

Read More
Rare Diseases: The Role of Social Media in Patient Recruitment

Since the passing of the Orphan Drug Act in 1983, the rate of drug development in the United States has seen…

Read More
When Pharma Trials Fail: A Case Study of Funky Cold Medina

Rapper Tone Loc could have been a part of a clinical research organization (CRO), yet he instead took to singing songs…

Read More
Want More Cures? Modernize Clinical Trials

As the federal government creates a plan to speed the pace of drug development in the U.S., one specialty contract research…

Read More
2014 FDA Drug Approvals at 18-year High, but How Much New Ground Are We Breaking?

As the New Year bells chimed in 2015, the curtains drew shut on this century’s best year for novel-drug approvals. The…

Read More
What You Cared About in 2014

As the year closes, one can’t help but reflect. So, we take a look back at our most popular blog posts…

Read More
The J.P. Morgan Healthcare Conference: Worth the Fuss?

Attendance is by invitation only. There’s no trade show floor. And, good luck tracking down information on speakers and schedules if…

Read More
2014 Snapshot: How the Golden State Fared in Biotech

California is known as an innovator in the national and global life sciences community, garnering more federal biomedical research dollars than…

Read More